Michael Anthony Zybko, DO | |
4401 Wornall Rd, Kansas City, MO 64111-3220 | |
(816) 932-0340 | |
(816) 932-3148 |
Full Name | Michael Anthony Zybko |
---|---|
Gender | Male |
Speciality | Hospitalist |
Experience | 14 Years |
Location | 4401 Wornall Rd, Kansas City, Missouri |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1174835854 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
208M00000X | Hospitalist | 2013028525 (Missouri) | Primary |
208M00000X | Hospitalist | 05-36715 (Kansas) | Secondary |
Facility Name | Location | Facility Type |
---|---|---|
Saint Lukes North Hospital | Kansas city, MO | Hospital |
Saint Luke's East Hospital | Lees summit, MO | Hospital |
St Lukes Hospital Of Kansas City | Kansas city, MO | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Saint Lukes Physician Group Inc | 3577476894 | 1070 |
Saint Lukes Physician Group Inc | 3577476894 | 1070 |
News Archive
A common treatment for attention deficit/hyperactivity disorder, prescribed millions of times a year, may change the brain in the same ways that cocaine does, a new study in mice suggests.
"G20 ministers gather in Paris Friday to hammer out common criteria for measuring global economic imbalances at a two-day session that host France hopes will lead to an overhaul of world finance," Agence France-Presse reports.
Consumption of ultra-processed foods has increased over the past two decades across nearly all segments of the U.S. population, according to a new study by researchers at NYU School of Global Public Health.
Titan Pharmaceuticals, Inc today announced that Vanda Pharmaceuticals, Inc. reported its entry into an exclusive agreement with Novartis Pharma AG to commercialize and develop Fanapt™ (iloperidone) in the U.S. and Canada. Fanapt™, an atypical anti-psychotic, was approved by the U.S. Food and Drug Administration earlier this summer for the acute treatment of schizophrenia in adults.
› Verified 3 days ago
Entity Name | Saint Lukes Physician Group Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1093263717 PECOS PAC ID: 3577476894 Enrollment ID: O20031111000818 |
News Archive
A common treatment for attention deficit/hyperactivity disorder, prescribed millions of times a year, may change the brain in the same ways that cocaine does, a new study in mice suggests.
"G20 ministers gather in Paris Friday to hammer out common criteria for measuring global economic imbalances at a two-day session that host France hopes will lead to an overhaul of world finance," Agence France-Presse reports.
Consumption of ultra-processed foods has increased over the past two decades across nearly all segments of the U.S. population, according to a new study by researchers at NYU School of Global Public Health.
Titan Pharmaceuticals, Inc today announced that Vanda Pharmaceuticals, Inc. reported its entry into an exclusive agreement with Novartis Pharma AG to commercialize and develop Fanapt™ (iloperidone) in the U.S. and Canada. Fanapt™, an atypical anti-psychotic, was approved by the U.S. Food and Drug Administration earlier this summer for the acute treatment of schizophrenia in adults.
› Verified 3 days ago
Entity Name | Saint Lukes Hospital Of Chillicothe |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1245433127 PECOS PAC ID: 0143130393 Enrollment ID: O20041014000548 |
News Archive
A common treatment for attention deficit/hyperactivity disorder, prescribed millions of times a year, may change the brain in the same ways that cocaine does, a new study in mice suggests.
"G20 ministers gather in Paris Friday to hammer out common criteria for measuring global economic imbalances at a two-day session that host France hopes will lead to an overhaul of world finance," Agence France-Presse reports.
Consumption of ultra-processed foods has increased over the past two decades across nearly all segments of the U.S. population, according to a new study by researchers at NYU School of Global Public Health.
Titan Pharmaceuticals, Inc today announced that Vanda Pharmaceuticals, Inc. reported its entry into an exclusive agreement with Novartis Pharma AG to commercialize and develop Fanapt™ (iloperidone) in the U.S. and Canada. Fanapt™, an atypical anti-psychotic, was approved by the U.S. Food and Drug Administration earlier this summer for the acute treatment of schizophrenia in adults.
› Verified 3 days ago
Mailing Address | Practice Location Address |
---|---|
Michael Anthony Zybko, DO 901 E 104th St, Kansas City, MO 64131-4517 Ph: (816) 502-8752 | Michael Anthony Zybko, DO 4401 Wornall Rd, Kansas City, MO 64111-3220 Ph: (816) 932-0340 |
News Archive
A common treatment for attention deficit/hyperactivity disorder, prescribed millions of times a year, may change the brain in the same ways that cocaine does, a new study in mice suggests.
"G20 ministers gather in Paris Friday to hammer out common criteria for measuring global economic imbalances at a two-day session that host France hopes will lead to an overhaul of world finance," Agence France-Presse reports.
Consumption of ultra-processed foods has increased over the past two decades across nearly all segments of the U.S. population, according to a new study by researchers at NYU School of Global Public Health.
Titan Pharmaceuticals, Inc today announced that Vanda Pharmaceuticals, Inc. reported its entry into an exclusive agreement with Novartis Pharma AG to commercialize and develop Fanapt™ (iloperidone) in the U.S. and Canada. Fanapt™, an atypical anti-psychotic, was approved by the U.S. Food and Drug Administration earlier this summer for the acute treatment of schizophrenia in adults.
› Verified 3 days ago
Subashis Paul, M.D. Hospitalist Medicare: Medicare Enrolled Practice Location: 2301 Main St, Kansas City, MO 64108 Phone: 816-395-3558 | |
Tyler Porter, MD Hospitalist Medicare: Medicare Enrolled Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 | |
Christine M. Sankpill, M.D. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Anuhya Caipa Young, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
David A Wooldridge, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
Peter Lebourveau, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 4401 Wornall Rd, Kansas City, MO 64111 Phone: 816-932-0340 Fax: 816-932-3148 | |
David C Hermanns, MD Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 2301 Holmes St, Kansas City, MO 64108 Phone: 816-404-1000 |